Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings

​​​​This presentation examines new systemic corticosteroid use, including clinical and demographic characteristics and utilization patterns, among non-hospitalized patients with COVID-19 from April 2020 - September 2021 in four large U.S. real-world data sources. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.